DDB1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.160800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.959600E-01
Normal-vs-Stage2
8.561600E-01
Normal-vs-Stage3
4.383600E-01
Normal-vs-Stage4
3.560600E-01
Stage1-vs-Stage2
6.898200E-01
Stage1-vs-Stage3
1.394180E-01
Stage1-vs-Stage4
5.778800E-01
Stage2-vs-Stage3
1.814850E-01
Stage2-vs-Stage4
4.264200E-01
Stage3-vs-Stage4
1.528650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.536800E-01
Normal-vs-AfricanAmerican
4.247600E-01
Normal-vs-Asian
9.299600E-01
Caucasian-vs-AfricanAmerican
3.612400E-01
Caucasian-vs-Asian
8.927800E-01
AfricanAmerican-vs-Asian
4.634400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.140600E-01
Normal-vs-Female
7.114800E-01
Male-vs-Female
2.749000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.918000E-01
Normal-vs-Age(41-60Yrs)
3.833400E-01
Normal-vs-Age(61-80Yrs)
9.982400E-01
Normal-vs-Age(81-100Yrs)
9.684200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.111000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.635000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.941400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.843000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.311190E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.511200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.178800E-01
Normal-vs-Daily Drinker
8.070600E-01
Normal-vs-Weekly Drinker
9.963600E-01
Normal-vs-Occasional Drinker
3.256200E-01
Normal-vs-Social Drinker
4.493600E-01
Non Drinker-vs-Daily Drinker
9.955600E-01
Non Drinker-vs-Weekly Drinker
6.666200E-01
Non Drinker-vs-Occasional Drinker
2.314000E-02
Non Drinker-vs-Social Drinker
6.771800E-02
Daily Drinker-vs-Weekly Drinker
6.672400E-01
Daily Drinker-vs-Occasional Drinker
2.592100E-02
Daily Drinker-vs-Social Drinker
7.270300E-02
Weekly Drinker-vs-Occasional Drinker
1.132420E-01
Weekly Drinker-vs-Social Drinker
2.212200E-01
Occasional Drinker-vs-Social Drinker
7.910600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.180800E-01
Normal-vs-Grade 2
7.980400E-01
Normal-vs-Grade 3
7.500000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.650000E-01
Grade 1-vs-Grade 3
3.166200E-01
Grade 1-vs-Grade 4
8.180800E-01
Grade 2-vs-Grade 3
2.195600E-01
Grade 2-vs-Grade 4
7.980400E-01
Grade 3-vs-Grade 4
7.500000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.972200E-01
Normal-vs-NonDiabetic
7.986200E-01
Diabetic-vs-NonDiabetic
2.261200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.758200E-01
Normal-vs-NoPancreatitis
8.970000E-01
Pancreatitis-vs-NoPancreatitis
2.038400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.468600E-01
Normal-vs-N1
8.933200E-01
N0-vs-N1
2.024800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.726600E-01
Normal-vs-TP53-NonMutant
8.118000E-01
TP53-Mutant-vs-TP53-NonMutant
7.387700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
